Tipiracil Hydrochloride; Trifluridine Patent Expiration
Tipiracil Hydrochloride; Trifluridine is Used for treating metastatic colorectal cancer in patients previously treated with specific chemotherapy combinations. It was first introduced by Taiho Oncology Inc
Tipiracil Hydrochloride; Trifluridine Patents
Given below is the list of patents protecting Tipiracil Hydrochloride; Trifluridine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lonsurf | US10456399 | Method for treating cancer patients with severe renal impairment | Feb 03, 2037 | Taiho Oncology |
| Lonsurf | US10960004 | Method for treating cancer patients with severe renal impairment | Feb 03, 2037 | Taiho Oncology |
| Lonsurf | US9943537 | Antitumor agent and antitumor effect enhancer | Sep 05, 2034 | Taiho Oncology |
| Lonsurf | US10457666 | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | Jun 17, 2034 | Taiho Oncology |
| Lonsurf | US9527833 | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | Jun 17, 2034 | Taiho Oncology |
| Lonsurf | USRE46284 | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor | Sep 22, 2029 | Taiho Oncology |
| Lonsurf | US7799783 | Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor | Dec 16, 2026 | Taiho Oncology |
| Lonsurf | US6479500 | Agents for alleviating side effects |
Mar 16, 2020
(Expired) | Taiho Oncology |
| Lonsurf | US5744475 | Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
Mar 28, 2016
(Expired) | Taiho Oncology |
Tipiracil Hydrochloride; Trifluridine's Family Patents
Explore Our Curated Drug Screens
Tipiracil Hydrochloride; Trifluridine Generic API Manufacturers
Several generic applications have been filed for Tipiracil Hydrochloride; Trifluridine.
Given below is the list of companies who have filed for Tipiracil Hydrochloride; Trifluridine generic, along with the locations of their manufacturing plants worldwide.
1. NATCO
Natco Pharma Ltd has filed for 2 different strengths of generic version for Tipiracil Hydrochloride; Trifluridine. All of these versions come by the name TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE. Given below are the details of the strengths of this generic introduced by Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 6.14MG BASE; 15MG | tablet | Prescription | ORAL | AB | Jun 13, 2023 |
| EQ 8.19MG BASE; 20MG | tablet | Prescription | ORAL | AB | Jun 13, 2023 |
Manufacturing Plant Locations New
Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Kingdom |
| |||||||||||||
| India |
| |||||||||||||